Athanor Capital, LP Coherus Bio Sciences, Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $171,885 - $204,536	-13,273 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $267,159 - $396,292	-18,527 Reduced 58.26%	13,273 $194,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $53,157 - $60,797	-3,210 Reduced 9.17%	31,800 $553,000
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $59,507 - $67,984	3,418 Added 10.82%	35,010 $642,000
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $455,872 - $605,302	31,592 New	31,592 $564,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $97.9M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.